8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) July 6, 2000 SurModics, Inc. (Exact Name of Registrant as Specified in Its Charter) Minnesota (State of Other Jurisdiction of Incorporation) 0-18050 41-1356149 (Commission File Number) (I.R.S. Employer Identification No.) 9942 West 74th Street Eden Prairie, Minnesota 55344 (Address of Principal Executive Offices) (Zip Code) (612) 829-2715 (Registrant's Telephone Number, Including Area Code) Not Applicable (Former Name or Former Address, if Changed Since Last Report) Item 5 Other Events. On July 6, 2000, SurModics, Inc. issued a press release announcing it has entered into a licensing and development agreement with Motorola, Inc.'s BioChip Systems unit which grants Motorola exclusive rights to SurModics' proprietary PhotoLink(R) technology for use in Motorola's biochips. A copy of the press release is filed as Exhibit 99 to this Form 8-K. Item 7. Financial Statements and Exhibits (a) Financial Statements of Businesses Acquired: Not Applicable. (b) Pro Forma Financial Information: Not Applicable. (c) Exhibits: See Exhibit Index on page following Signatures. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURMODICS, INC. Date: July 6, 2000 By /s/ James C. Powell James C. Powell President & Chief Operating Officer SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 EXHIBIT INDEX to FORM 8-K SURMODICS, INC. Exhibit Number Exhibit Description -------------- ------------------- 99 Press release dated July 6, 2000.